South Korea-based NTL HEALTHCARE, a women's health AI company, has announced the global launch of CerviCARE® AI AT, an on-premises version of its AI-powered cervical screening system, CerviCARE® AI.
CerviCARE® AI uses artificial intelligence (AI) to analyse cervical images and support healthcare professionals in making clinical decisions for cervical screening. CerviCARE® AI AT introduces an on-premises deployment option, enabling AI analysis and related data management within healthcare institutions' IT environments.
As medical AI adoption expands, healthcare institutions are considering not only AI performance but also how medical data is processed, stored, and managed. CerviCARE® AI AT is installed on local PCs within healthcare institutions and can operate without a dedicated server or cloud infrastructure.
This on-premises architecture reduces the need to transmit or store cervical images and related data outside the healthcare institution. It also enables institutions to manage medical data within their own IT environments, giving them greater control over data management.
With the launch of CerviCARE® AI AT, NTL HEALTHCARE now offers two deployment options for CerviCARE® AI—SaaS and on-premises—expanding the choices available to healthcare institutions so they can deploy and operate the AI screening platform according to their individual needs and environments.
